Address
Email address
Phone number
https://santen.comSanten Pharmaceutical Co., Ltd | Happiness with Vision (santen.com)Santen is a global leader in ophthalmological research and development and the production and marketing of related pharmaceuticals and medical devices. Guided by the Santen motto
Name
Santen Oy Eesti Filiaal
Registry code
11460851
Type
FIL - Branch
Status
Registered
Foundation date
18.01.2008 (16)
Financial year
01.03-28.02
Capital
20 000 000.00 €
Activity
82991 - Other business support service activities n.e.c.
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Pille Kink 23.06.1970 (54) | - | Branch manager | - |
| 2019 01.06.2021 | 2020 01.11.2021 | 2021 14.11.2022 | 2022 18.10.2023 | |
|---|---|---|---|---|
| Total Revenue | - | - | - | - |
| Net profit (loss) for the period | - | - | - | - |
| Profit Margin | - | - | - | - |
| Current Assets | - | - | - | - |
| Fixed Assets | - | - | - | - |
| Total Assets | - | - | - | - |
| Current Liabilities | - | - | - | - |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | - | - | - | - |
| Employees | - | - | - | - |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | - | 18 277.03 € | 19 365.8 € | 2 |
| 2023 Q4 | - | 17 335.85 € | 20 755.69 € | 2 |
| 2023 Q3 | - | 31 961.81 € | 34 142.99 € | 2 |
| 2023 Q2 | - | 17 771.34 € | 18 699.37 € | 2 |
| 2023 Q1 | - | 18 045.49 € | 19 017.7 € | 2 |
| 2022 Q4 | - | 18 561.5 € | 19 577.14 € | 2 |
| 2022 Q3 | - | 32 095.89 € | 34 250.6 € | 2 |
| 2022 Q2 | - | 16 850.85 € | 17 722.5 € | 2 |
| 2022 Q1 | - | 16 240.15 € | 17 041.1 € | 2 |
| 2021 Q4 | - | 15 895.34 € | 18 356.74 € | 2 |
| 2021 Q3 | - | 25 787.57 € | 27 411.37 € | 2 |
| 2021 Q2 | - | 15 264.65 € | 15 985.42 € | 2 |
| 2021 Q1 | - | 16 458.27 € | 17 296.87 € | 2 |
| 2020 Q4 | - | 21 768.7 € | 22 872.05 € | 2 |
| 2020 Q3 | - | 17 784.74 € | 18 917.19 € | 2 |
| 2020 Q2 | - | 12 888.18 € | 14 705.66 € | 2 |
| 2020 Q1 | - | 10 518.78 € | 11 093.04 € | 1 |
